Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

425.34 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
25 26 Next >
Best Robotic Stocks For 2023
As technology continues to advance, robotics has become a booming industry. In addition to robotics, Machine Learning and AI have become a hot investing topic. Let’s take a closer look at some of the... 
Via Talk Markets
DeSantis Vs. Disney, Alibaba Spinoffs Cloud Business, Apple Bans Internal ChatGPT Use: Today's Top Stories
Bloomberg 
Via Benzinga
The First Test To Detect Preeclampsia From Thermo Fisher Gets FDA Approval
The FDA has reportedly approved Thermo Fisher Scientific Inc's (NYSE: TMO) blood test for preeclampsia, which causes pregnancy-related illness and death, to aid in the risk assessment of pregnant... 
Via Benzinga
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays to Aid in the Risk Assessment of Preeclampsia
From Thermo Fisher Scientific Inc.
Via Business Wire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,200 Today
Via Benzinga
Check Out What Whales Are Doing With TMO
Via Benzinga
This Is What Whales Are Betting On Thermo Fisher Scientific
Via Benzinga
Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report
From Thermo Fisher Scientific Inc.
Via Business Wire
3 AI Stocks That Famed Investor Cathie Wood Is Betting On
Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
A New Era In Regenerative Medicine? BioRestorative Therapies (NASDAQ: BRT) Reports Leading The Expansion Of The Adipose-Derived Stem Cell Therapy Market
Brown Adipose-Derived Stem Cell (BADSC) therapy has emerged as a groundbreaking innovation in regenerative medicine, capturing the attention of scientists, clinicians and investors alike. 
Via Benzinga
Analyst Expectations for Thermo Fisher Scientific's Future
Via Benzinga
$1000 Invested In Thermo Fisher Scientific 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Thermo Fisher Scientific Unusual Options Activity
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Syneos Health Close To Being Acquired For $7B - Elliott, Patient Square and Veritas Investment Consortium Lead Deal
A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion, including... 
Via Benzinga
Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets
From Thermo Fisher Scientific Inc.
Via Business Wire
Advent, Warburg Pincus Lead Multi-Billion Buyout Bid For Baxter's BioPharma Solutions
A buyout consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire Baxter International Inc's (NYSE: BAX)  
Via Benzinga
The 3 Most Promising Nanotechnology Stocks to Buy
These nanotechnology stocks represent cutting edge materials advances and commercial utility, providing strong long-term upside. 
Via InvestorPlace
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
These two companies are leaders in their industries, and they're relatively safe, too. 
Via The Motley Fool
Thermo Fisher Scientific to Present at BofA Securities 2023 Healthcare Conference on May 10th, 2023
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
ASLAN Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
From ASLAN PHARMACEUTICALS LIMITED
Via GlobeNewswire
Meta Platforms To Rally Around 67%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for Old Dominion Freight Line, Inc. (NASDAQ: ODFL) from $339 to $334. Morgan Stanley analyst Ravi Shanker maintained an Equal-Weight rating. Old Dominion shares fell... 
Via Benzinga
Thermo Fisher Takes Q1 Hit From Fall In Life Sciences Segment, Misses Street Expectation
Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q1 revenue of $10.71 billion, down 9% Y/Y, beat 
Via Benzinga
Earnings Scheduled For April 26, 2023
Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion. 
Via Benzinga
Thermo Fisher Scientific Reports First Quarter 2023 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
2 Steady Stocks to Buy and Hold Forever
These two companies stand the test of time and can likely make their investors richer, too. 
Via The Motley Fool
Bear Market Champions: 2 Resilient Stocks to Weather Any Storm
In uncertain times, resilient businesses can still thrive. 
Via The Motley Fool
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named SPDR S&P Biotech ETF (NYSE: XBI), which is trading in a tight range < 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback